US EditionPublished • loading... • Updated
Renal Cell Carcinoma: Immune Patterns in Metastases Determine Treatment Success
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Würzburg – The chances of success of immunotherapy with checkpoint inhibitors, to which approximately one in five people fails to respond, can be better predicted by transcriptome analysis in metastases than in the primary tumor. This is the conclusion of a study in the Journal for ImmunoTherapy of Cancer (2025; DOI: 10.1136/jitc-2025-012991). The...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
